Background: Angiopoietin (Ang)-1 and Ang-2, and their shared receptor Tie2, are expressed in rheumatoid arthritis (RA) synovial tissue, but the cellular targets of Ang signalling and the relative contributions of Ang-1 and Ang-2 to arthritis are poorly understood.
Results: Expression of synovial Tie2 and p-Tie2 was similar in RA and PsA. Tie2 activation in RA patient synovial tissue was predominantly localised in synovial macrophages and was expressed by human macrophages. Ang-1 and Ang-2 stimulated activation of multiple intracellular signalling pathways, and cooperated with tumour necrosis factor to induce macrophage interleukin 6 and macrophage inflammatory protein 1α production. Ang-2 selectively suppressed macrophage thrombospondin-2 production. Ang-2 neutralisation significantly decreased disease severity, synovial inflammation, neo-vascularisation and joint destruction in established CIA.
Conclusion:
The authors identify synovial macrophages as primary targets of Ang signalling in RA, and demonstrate that Ang-2 promotes the pro-inflammatory activation of human macrophages. Ang-2 makes requisite contributions to pathology in CIA, indicating that targeting Ang-2 may be of therapeutic benefit in the treatment of RA.
INTRODUCTION
Angiogenesis of new vessels from existing vessels plays a pivotal role in mammalian development, and in the initiation and maintenance of chronic inflammatory diseases and tumour growth [1] . Receptor tyrosine kinase Tie2 ligation by angiopoeitin 1 (Ang-1) and Ang-2 makes contributions to angiogenesis and blood vessel remodelling which are critically distinct from vascular endothelial growth factor receptor ligation [2] . Like vascular endothelial growth factor, Ang-1 and Tie2 are required for embryonic angiogenesis [3, 4] . Initial studies indicated that Ang-2 may act as an endogenous antagonist of Ang-1 during development, but these cytokines play distinct roles in promoting vasculature remodelling [5, 6] . In mice, stable systemic Ang-1 levels maintain vascular stability and suppress inflammationinduced vascular permeability and oedema [7] . By contrast, Ang-2 is up-regulated during inflammation, and promotes recruitment of neutrophils by activated endothelial cells (ECs) [8] .
Infiltration of solid murine and human tumours by Tie2-expressing monocytes/macrophages (TEMs) is critical in cancer establishment and growth [9] [10] [11] . Ang2 stimulation of TEMs potentiates tumour growth, in part by promoting immunosuppressive properties of TEMs, including interleukin 10 (IL-10) secretion [11] [12] [13] . Tie2 signalling is also thought to be important in chronic inflammatory diseases. In patients with rheumatoid arthritis (RA) and other forms of inflammatory arthritis, such as psoriatic arthritis (PsA), increased vascularity and new blood vessel formation promotes destruction of the affected joints by facilitating the influx of nutrients and inflammatory cells [14, 15] . Histological changes in the synovial microvasculature precede local inflammation in patients presenting with mono-arthritis prior to fulfilment of classification criteria for RA, and in both RA and PsA, expression of angiogenic factors and EC activation markers are closely associated with, and suggested to be prognostic for disease activity and joint destruction [16] [17] [18] . Successful treatment of inflammatory arthritis is closely associated with decreases in systemic and local expression of angiogenic factors and endothelial activation markers [19] [20] [21] [22] . This has indicated that modulation of angiogenesis may be useful in the treatment of RA, and direct targeting of newly formed blood vessels in animal models of RA prevents inflammation and joint destruction [23] . In addition, specific blockade of Tie2 signalling in vivo prevents angiogenesis and joint destruction in the murine CIA model of RA [24, 25] . However, it is unclear whether Ang-1 and Ang-2 make independent contributions to pathology in inflammatory arthritis.
Ang-1, Ang-2 and Tie2 are readily detected in the synovial tissues of patients with RA and PsA [17, [26] [27] [28] [29] . Tie2 expression in synovial tissue is detected on ECs, stromal fibroblast-like synoviocytes (FLS) and macrophages, and in vitro, tumour necrosis factor (TNF) can induce EC Tie2 expression.24 Ang-1 and Ang-2 are produced in situ by RA FLS, macrophages and ECs [17, [27] [28] [29] . Ang-1 stimulation of Tie2 expressed on ECs and FLS can promote synovial angiogenesis and cartilage destruction in synovial tissue, respectively [24, 30] . Effects of Ang-2 on RA synovial cells have not been examined, but a role for Ang-2 in the pathology of human inflammatory arthritis is suggested by observations that synovial tissue and synovial fluid Ang-2 levels are highly elevated compared with Ang-1 in patients with RA and PsA [17, 18] . In addition, serum Ang-2 levels are associated with disease activity in recent onset of RA [31] . Here, we examined the potential role of myeloid Tie2 signalling in RA, and the consequences of Ang-2 blockade in murine CIA.
MATERIALS AND METHODS

Patients, synovial biopsy acquisition and synovial tissue analysis
Synovial biopsies were obtained by needle arthroscopy as previously described from clinically active joints of RA (n=20) and PsA (n=19) patients who fulfilled the American College of Rheumatology criteria for RA and the classification criteria for psoriatic arthritis, respectively [32] [33] [34] . Patient characteristics for both cohorts have been previously described in detail [35] . All patients gave their written informed consent prior to inclusion, and this study was approved by the Medical Ethics Committee of the Academic Medical Center, University of Amsterdam. Sections were processed for immunohistochemical and immunofluorescent analyses as previously described [36] [37] .
Monocyte purification, macrophage differentiation and analysis
Human peripheral blood mononuclear cells were isolated from blood of healthy volunteer donors and RA patients by Ficoll, and monocytes were either used immediately or differentiated in to macrophages as previously described [38] . Full details of monocyte isolation, macrophage culture, differentiation, characterisation by flow cytometry and stimulation and analysis by immunoblotting and ELISA are described in the online supplementary material.
Animals, and induction and assessment of CIA
DBA/1 male mice were purchased from either Harlan (Horst, The Netherlands) or Jackson Laboratory (Bar Harbor, Maine, USA). Animals were housed in specific pathogen-free conditions at Alderley Park, Astra Zeneca, in compliance with Home Office Regulations (UK). All animal experiments were approved by the Animal Welfare and Ethics Committee (Alderley Park). Mice (males, 6-7 weeks of age) were immunised by tail base injection on day 0 with an emulsion of rat type II collagen (100 µg, MD Biosciences Gmbh, Zurich, Switzerland) and complete freund's adjuvant (1 mg/ml, Difco), followed by boosting with 
Statistical analyses
For in vivo studies, analysis was performed using analysis of variance (ANOVA) with post hoc Dunnetts analysis on Windows Graphpad Prism 4. For in vitro experiments, analysis was performed using Windows Graphpad Prism 5 (GraphPad Software). Flow cytometry and ELISA results were expressed as the mean ± SEM. Potential differences between samples or scores were analysed by Student's t-test or non-parametric Mann-Whitney U or KruskalWallis tests, as appropriate. p Values ≤0.05 were considered significant.
RESULTS
Tie2 is activated in RA synovial tissue macrophages
We first examined the expression and activation status of Tie2 in RA and PsA synovial tissue. 
Tie2 is functionally expressed on human macrophages
Consistent with published studies, Tie2 was readily detected on the surface of freshly isolated human CD14+ peripheral blood mononuclear cells, and on peripheral bloodderived human macrophages ( figure 2A, B Stimulation with either Ang-1 or Ang-2 alone failed to induce macrophage IL-6 production compared with unstimulated macrophages (figure 3B). However, in the presence of TNF (10 ng/ml), Ang-1 (200 ng/ml) significantly increased IL-6 production compared with TNF treatment alone (p<0.05). Similar enhancing effects were observed with Ang-2 (p<0.01), although lower concentrations of Ang-2 (20 ng/ml) also significantly enhanced IL-6 production. The effects of Ang-1 and Ang-2 on TNF-induced IL-6 production were selective, 110 as both failed to influence LPS-induced IL-6 production. When lower concentrations of TNF were used, Ang-1 synergistically enhanced IL-6 production (p<0.01), while only a trend towards enhanced IL-6 production was observed with Ang-2 ( figure 3C ). Ang-1 costimulation with 1 ng/ml TNF created a biological window in which to identify specific Tie2 signalling pathways contributing to IL-6 production. Pre-incubation of macrophages with pharmacological inhibitors of NF-κB (BAY 11-7082) and MEK/ERK (U0126) but not PKB, JNK or p38 (SB23580) significantly reduced the capacity of Ang-1 to enhance IL-6 production ( figure 3D ). Under these experimental conditions, Ang-1 and TNF cooperatively enhanced macrophage NF-κB, ERK and PKB activation (supplemental figure 1) .
Ang-1 and Ang-2 differentially regulate macrophage angiogenic factor expression
Supernatants from experiments shown in figure 3 were pooled and screened using a proteomic array detecting defined secreted angiogenic factors (data not shown). In independent validation ELISA experiments, MIP-1α and IL-8 were not directly induced by stimulation with Ang-1 or Ang-2 alone (figure 4A). However, both Ang-1 and Ang-2 cooperated with TNF to stimulate MIP-1α production (p<0.01). Ang-1 (p<0.01) and Ang-2 (p<0.05) also synergised with lipopolysaccharide (LPS) to induce MIP-1α production. By contrast, IL-8 production in response to TNF or LPS was unaffected by Tie2 signalling. Constitutive matrix metalloproteinase (MMP)-1 (data not shown), MMP-9 and TIMP-1 production (figure 4B) were unchanged following TNF or LPS stimulation, alone or in combination with Ang-1 or Ang-2, as was secretion of TSP-1 ( figure 4C ). However, Ang-2 selectively suppressed spontaneous TSP-2 production, and TNF-and LPS-induced TSP-2 production (p<0.05). Together, these results indicate that macrophage Tie2 signalling, particularly following engagement by Ang-2, can promote a pro-inflammatory environment by enhancing cytokine and chemokine production while suppressing constitutive production of TSP-2, a natural inhibitor of MMPs and tissue retention of inflammatory cells.
Neutralisation of Ang-2 is protective in murine CIA
To determine the therapeutic potential of blocking Ang-2 function in inflammatory arthritis, we evaluated a neutralising, high affinity, fully humanised anti-Ang-2 antibody, 3.19.3, which prevents human and murine Ang-2 signalling to Tie2 in the murine CIA model of RA [39] . 9 and TIMP-1, and (C), and TSP-1 and TSP-2 production in tissue culture supernatants of granulocyte macrophage colony-stimulating factor (GM-CSF)-differentiated macrophages after 24 h incubation in medium alone, TNFα (10 ng/ml) or lipopolysaccharide (LPS) (1 µg/ml) in the absence (white bars) or presence of Ang-1 (200 ng/ml, gray bars) or Ang-2 (200 ng/ml, black bars). Bars represent the means and SEM of 6 independent experiments. *p<0.05, **p<0.01 versus cells not exposed to Ang-1 or Ang-2. 
DISCUSSION
In this study, we demonstrate that Tie2 is functionally expressed on activated proinflammatory macrophages, and identify synovial macrophages as primary targets of Tie2 signalling in RA. Ang-2, alone, or in combination with TNF, can contribute to the inflammatory activation of macrophages, and as demonstrated by in vivo neutralisation experiments, Ang-2 is required for pathology in murine CIA. Our observation that Tie2 activation in RA synovial tissue is largely restricted to infiltrating macrophages is striking, as it necessitates reassessment of the interplay between angiogenic factors, innate immunity and pathology in chronic inflammatory disease. Consistent with previous studies, we observed that Tie2 was expressed by ECs, FLS and macrophages in RA synovial tissue [27] . However, ECs and FLS expressing p-Tie2 were only rarely detected. By contrast, p-Tie2 was observed in the majority of RA synovial macrophages. Preferential activation of macrophages may arise from differential proximity of this cell population to other synovial cells producing Ang-1 and Ang-2, which requires further experimental consideration, other cell populations in synovial tissue may express relatively higher levels of inhibitory Tie1, or macrophages might differ from other synovial cell populations in their sensitivity or exposure to soluble inhibitory Tie1 splice variants in vivo [40] . Direct and critical integration of angiogenic signalling with innate immune response components has recently been identified in tumour biology [9, 10] . Here, recruitment of TEMs, suggested to represent a distinct myeloid lineage commitment, is necessary for the establishment and growth of murine and human solid tumours [11, 41] . Prominent secreted gene products expressed by TEMs include cathepsin B, MMP-9 and IL-10, and expression of these factors, important for angiogenesis and immune regulation, is reinforced by Ang-2 stimulation [12] . Our studies demonstrate that Tie2 expression on differentiated human 6 macrophages can also contribute to pro-inflammatory activation of these cells via induction of IL-6 production, which pleiotropically supports cellular activation and survival in RA.
Macrophage Tie2 stimulation also enhances production of MIP-1α, a chemokine expressed at high levels in the RA synovium and shown to play an essential inflammatory role in animal models of RA [42] . Ang-1 or Ang-2 stimulation alone was unable to generate macrophage IL-6 or MIP-1α expression, but instead synergised with TNF (and in the case of MIP-1α, also LPS) to support gene expression, a co-stimulatory property strikingly similar to the combined effects of Tie2 ligation and TNF stimulation during EC activation [8] . This is reinforced by our observation that Ang-1, and to a lesser extent Ang-2, can increase IL-6 production in the presence of low concentrations of TNF.
Lastly, we observe a specific role for Ang-2 in dampening both constitutive and agonistinduced macrophage TSP-2 production. TSP-2 broadly orchestrates angiogenic remodelling, via the promotion of EC apoptosis, interference with integrin ligand binding, and inhibition of MMPs [43] . In mice lacking TSP-2, defects are observed in extracellular matrix remodelling during angiogenesis, associated with increased MMP-9 deposition and gelatinase activity [44] . Overexpression of TSP-2 inhibits vascularisation, inflammation and lymphocyte accumulation in the human RA-severe combined immunodeficiency model of RA [45] . The ability of Ang-2 to stimulate macrophage chemokine production, while simultaneously suppressing TSP-2 output, may promote inflammatory leucocyte recruitment and retention, and facilitate MMP-driven tissue destruction in RA.
Gene therapy strategies delivering local expression of soluble Tie2 inhibit both angiogenesis and pathology in CIA [24, 25] . Using 3.19.3, a neutralising Ang-2 antibody, we demonstrate a specific and critically important pro-inflammatory role for Ang-2 in disease progression of established clinical arthritis in murine CIA. Ang-2 neutralisation blocked not only new vessel formation, but also reduced the number of inflammatory cells infiltrating arthritic joints, both of which are processes pivotal to the development of arthritis [1, 46] . The clinical, histological and radiological protection provided by Ang-2 blockade closely recapitulates effects observed following adenoviral delivery of soluble Tie2 receptor during murine CIA [25] . That synovial macrophages are primary targets of Ang signalling in RA is noteworthy from the perspective of therapeutic application. Synovial macrophage numbers and cytokine production are tightly associated with disease activity, and decreases in synovial sublining CD68+ macrophages precede and predict effective clinical responses to therapy [47, 48] . Therefore, therapies specifically targeting macrophage retention and activation in the synovium are thought to be of future clinical benefit [46] . The capacity of Ang-2 to support both these features, and recent findings that serum levels of Ang-2 are associated with inflammation and disease activity in recent onset RA, warrants further assessment of the unique contributions of macrophage Tie2 signalling to RA, and comparative analysis of Ang-1 blockade in inflammatory arthritis [17, 27, 29, 31] .
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